Labquality EQAS by Aurevia
Mycobacterium tuberculosis, drug resistance, nucleic acid detection
CLINICAL MICROBIOLOGY
Scheme information
Service
Labquality EQAS
Scheme
Mycobacterium tuberculosis, drug resistance, nucleic acid detection
Service provider
Aurevia
Accreditation
ISO/EN 17043 (PT02/FINAS)
Status
Running
Target
Laboratories
Coverage
Analytical phase
Rounds
4
Distributions
Globally available
Coordinators
Jaana Paakkanen
Experts
Silja Mentula
Products
5230 /
Mycobacterium tuberculosis, drug resistance, nucleic acid detection
Samples: 2 simulated samples, 1 mL
Type: Physical sample
Examinations: Mycobacterium tuberculosis nucleic acid detection, rifampicin susceptibility and isoniazid susceptibility
Additional information:
5231 /
Mycobacterium tuberculosis, drug resistance, nucleic acid detection, extra set of samples
Samples: 2 simulated samples, 1 mL
Type: Physical sample
Examinations:
Additional information: Only in connection with scheme 5230
Contact us
Jaana Paakkanen
EQA Coordinator
jaana.paakkanen@aurevia.com
+358 9 8566 8200